Briviact

Medicinal product

(Invented) name

Briviact

Active substance (s)

Brivaracetamas

Strength

100 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX23, Brivaracetam

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Brivaracetamas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65039	79535	1079535	lizdinė plokštelė	N14		Receptinis	EU/1/15/1073/017	Netiekiama	-	-	No	-	-
65040	79536	1079536	lizdinė plokštelė	N56		Receptinis	EU/1/15/1073/018	Netiekiama	-	-	No	-	-
65041	79537	1079537	dalomoji lizdinė plokštelė	N100x1		Receptinis	EU/1/15/1073/019	Netiekiama	-	-	No	-	-
65042	79538	1079538	lizdinė plokštelė	N168 (3x56) (sudėtinė)		Receptinis	EU/1/15/1073/020	Netiekiama	-	-	No	-	-
65984	80498	1080498	dalomoji lizdinė plokštelė	N14x1		Receptinis	EU/1/15/1073/027	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas